Trexquant Investment LP Harvard Bioscience Inc Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.28 - $6.42 $128,326 - $251,176	-39,124 Reduced 61.92%	24,065 $87,000
Q1 2022 May 13, 2022	BUY	$5.16 - $7.14 $220,755 - $305,463	42,782 Added 209.64%	63,189 $392,000
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $129,992 - $166,929	20,407 New	20,407 $144,000
Q2 2021 Aug 12, 2021	SELL	$5.44 - $8.4 $75,882 - $117,171	-13,949 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.91 - $6.99 $54,540 - $97,503	13,949 New	13,949 $76,000
Q4 2018 Feb 13, 2019	SELL	$3.03 - $5.0 $51,737 - $85,375	-17,075 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$5.0 - $6.65 $85,375 - $113,548	17,075 New	17,075 $90,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.